Drug repurposing in the era of COVID ‐19: a call for leadership and government investment-Reference-Cited by-同舟云学术

Drug repurposing in the era of COVID ‐19: a call for leadership and government investment

Published:2020-05-06 Issue:10 Volume:212 Page:450
ISSN:0025-729X
Container-title:Medical Journal of Australia
language:en
Short-container-title:Medical Journal of Australia

Author:

Martin Jennifer H¹²^ORCID,Bowden Nikola A¹

Affiliation:

1. University of Newcastle Newcastle NSW

2. Hunter New England Health Newcastle NSW

Publisher

AMPCo

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.5694/mja2.50603

Reference21 articles.

1. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

2. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?

3. European Medicines Agency.EMA gives advice on the use of non‐steroidal anti‐inflammatories for COVID‐19 [press release]. 18 Mar 2020.https://www.ema.europa.eu/en/news/ema-gives-advice-use-non-steroidal-anti-inflammatories-covid-19(viewed Apr 2020).

4. National AIDS Treatment Advocacy Project.The coronavirus conundrum: ACE2 and hypertension edition [press release]. 24 Mar 2020.http://natap.org/2020/COVID/032320_16.htm(viewed Apr 2020).

5. Coronavirus puts drug repurposing on the fast track

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can old drugs learn new tricks? Achieving registration and public subsidy listing for off‐patent medicines with novel therapeutic applications;Internal Medicine Journal;2023-07

2. Backgrounder—Part 2;Managing the Drug Discovery Process;2023

3. Application of antimicrobial, potential hazard and mitigation plans;Environmental Research;2022-12

4. Use of Human Lung Tissue Models for Screening of Drugs against SARS-CoV-2 Infection;Viruses;2022-10-31

5. The race for a COVID-19 vaccine: where are we up to?;Expert Review of Vaccines;2021-12-28